Neena Kadaba

Neena earned her PhD in chemistry at the California Institute of Technology (CalTech), and her work was published in Science. Neena was a recipient of the national P.E.O. Scholar Award, a Moore-Hufstedler Project Award, a DOW Career award, and was also a Ruth L. Kirschstein National Research Service Award recipient.  

Neena earned her undergraduate and master's degrees from the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, and she serves on MIT's Educational Council. 

Neena enjoys travel and exploring with her 2 kids and husband and hopes for more time for photography, reading and learning piano.

Neena Kadaba, an entrepreneur in residence at ATP, is a science-driven investor with over 15 years of experience building novel collaborations and partnerships to drive innovation. Neena is currently the interim CBO/COO of Deep Apple Therapeutics and a board member and interim COO at Nine Square Therapeutics.

Most recently, Neena was a Director at Quark Venture, where she served on the board of Eyevensys, IOME BIO, Calcimedica, and EyeYon on behalf of the Global Health Sciences Fund and led diligence for a number of additional investments.  Previously, she was the Director of Strategic Partnerships at QB3, an institute at the University of California, where she created new programs to accelerate startups and worked with QB3's venture fund, Mission Bay Capital. Prior to QB3, Neena was a Kauffman Fellow while she was an Associate in Venture Investment at Itochu Technology, Inc, the California office of Itochu, the Japanese trading company, and she began her career in venture at California Technology Ventures.

Neena Kadaba is a member of Kauffman Fellows Class 13, and served her fellowship at Itochu Technology, Inc. under the mentorship of Shinzo Nakano.